Recent publications of Keiji Nakamura, Ph.D., Pharma Forum Institute

   
  Emerginginmmunotherapy of cancer
        Pharma Japan No.2382 pp21-25 April 14 2014
   
  Current topics in the pharmaceutical industry: Emerging therapeutics with new mode of action
        Pharma Japan No.2361 pp16-20 November 11 2013
   
  A Number of blockbuster candidates Emerging from Japanese Pharmas’ Inhouse R&D: Dr Nakamura of Pharma Forum Institute (Mar.14.2013)
        Pharma Japan Friday March 15 2012
   
  Recent topics in hopeful drugs and candidates with unique mode of action: 1
        Pharma Japan No.2279 pp20-23 March 12 2012
   
  Recent topics in hopeful drugs and candidates with unique mode of action: 2
        Pharma Japan No.2280 pp 20-22 March 26 2012
   
 

悩める日本製薬企業の研究開発
     化学経済 3月号 27-33頁 2012

   
  Current promising drug candidates with a new mode of action
        Pharma Japan No 2249 pp16-19 August 8 2011
   
Recent topics in promising anticancer therapeutics
      Pharma Japan No 2221 pp18-20 January 17 2011
 
Pipelines of Japanese pharmaceutical companies
      New Drug Candidates Vol 21 No 11 pp 215-285 2011
 
New screening targets and candidate with new mode of action
      New Drug Candidates Vol 21 No 10 pp1-258 2010
 
Big Pharma losing flagships within a few years and shifting paradigm
      New Drug Candidates Vol 21 No 10 pp1-258 2010
 
Special issue for cancer
      New Drug Candidates Vol 21 No 7 pp1-268 September 2011
 
Annual pharmaceutical sales of Japanese companies in 2009
      New Drug Candidates Vol 21 No 5 pp141-229 June 2011
 

Diabetes and obesity: Review in the period between April 2009 and March 2010

      New Drug Candidates Vol 21 No 3 pp1-151 April 2010
 

Pharmaceutical licensing contracts

      New Drug Candidates Vol 21 No 2 pp129-155 March 2010
 

Dalcetrapib seen topping list of Japanese-origin blockbusters

      Scrip News February 18 2010
 
Prospect of Japanese pharmaceutical industry in 2010
      Pharma Japan No 2176 pp14-19 February 15 2010
 
R&D activity of Japanese Pharmaceutical companies in 2010
      New Drug Candidates Vol 20 No 9 pp1-226 December 2009
 
Pharmacology of aging and longevity: looking for anti-aging therapeutics
      Pharma Japan No 2152 pp16-19 November 2 2009
 
Cancer special issues
      New Drug Candidates Vol 20 No 7 pp1-252 September 2009
 
Annual sales and main drugs in Japanese pharmaceutical companies in 2008 from 2002
      New Drug Candidates Vol 20 No 6 pp179-230 July 2009
 
Biomarkers and related topics
      New Drug Candidates Vol 20 No 5 pp1-123 June 2009
 
Annual sales of main drugs and R&D cost of international majors in 2008 from 2004
      New Drug Candidates Vol 20 No 3 pp181-229 April 2009
 
Diabetes and obesity
      New Drug Candidates Vol 20 No 3 pp1-180 April 2009
 

Japanese pharmaceutical companies: blockbusters, candidates and pipelines

      New Drug Candidates Vol 19 No 11 pp293-378 January 2009
 

Patent expiration of blockbusters, and new breakthrough candidates from Japanese Pharmaceutical companies

      Pharma Japan No 2126 pp12-6 February 9 2009
 
Pharmaceutical licensing contracts of Japanese pharmaceutical companies and others
      New Drug Candidates Vol 20 No 2 pp-177-197 2009

Prasugrel to lead Japan-origin blockbusters (cited)

      SCRIP World Pharmaceutical News  February 10 2009
 
Diabetes and obesity: recent research and topics
      New Drug Candidates Vol 20 No 3 pp1-180 2009
 
International majors: drug sales in 2004 – 2008
      New Drug Candidates Vol 20 No 3 pp181-229 2009
 
Biomarkers: research and development in Jan 2007 – May 2009
      New Drug Candidates Vol 20 No 5 pp1-123 2009
 
Recent R&D activities of Japanese pharmaceutical companies
      New Drug Candidates Vol 19 No 10 2008
 
Recent R&D activities of international pharmaceutical majors
      New Drug Candidates Vol 19 No 9 2008
 
Prasugrel tops predicted Japan blockbusters
      SCRIP  No.3347 page 20-21, March 25 2008
 

Current new drug development in the Japanese pharmaceutical industry

      Pharma Japan No.2077 pp12-18 February 11 2008
 

Anticancer drugs and candidates under development of pharmaceutical
companies in the world

      New Drug Candidates Vol 18 No 7 pp1-452 July 2007
 

Prasugrel heads up potential Japanese-origin blockbusters

      SCRIP  No.3238 page 14 March 2nd 2007
  
Breakthrough candidates of Japanese pharmaceutical companies
      Pharma Japan No.2028 pp10-16 February 12 2007
      New Drug Candidates 17 pp319-379 January 2007
 
News from the Japanese Pharma Licensing Association (JPLA)
      Business Development & Licensing Journal, UK pp4-5, Autumn 2006
  

Blockbuster sales of international majors in 2005: rankings of companies and therapeutic areas

      Pharma Japan No.2004, pp 13-17 August 14 & 21
      New Drug Candidates 17 No.3 pp175-195 April 2006
 
Prasugrel set to top Japanese blockbusters
      SCRIP No.3140 page No. p24 March 14 2006
 
Blockbuster candidates from Japanese pharmaceutical companies in 2006
      Pharma Japan extra issue No.1988 April 17 2006
      New Drug Candidates 16 No.11 pp315-323 January 2006
 
Vascular calcification, ultimate consequence of vascular atherosclerosis
      New Drug Candidates 16 No.183-191 December 2005
      Pharma Japan No.1976 pp12-15, ibid No.1977 pp12-14 2006
 
  
A cluster of diseases, “metabolic syndrome”, reflecting on aging society
      New Drug Candidates 16 No.7 pp196-202 September 2005, and
       Pharma Japan No.1965 pp15-18 October 31 2005,
       
ibid No.1966 pp12-13 Nov 7 2005
   
Type 2 diabetes mellitus: expanding therapeutic strategy
       New Drug Candidates 16 No.4 pp203-214 May 2005, and
      Pharma Japan No.1947 pp17-20 June 20 2005;
      ibid No.1948 pp16-17 June 27 2005;
      
ibid No.1949 pp13-15 July 4 2005

  

Blockbuster candidates from Japanese pharmaceutical companies in 2005

       New Drug Candidates 15 No.11 pp313-316 January 2005.
  

Emerging new therapeutics against hypercholesterolemia and atherosclerosis: Lipitor, a golden standard ?

       New Drug Candidates 15 No.10 pp191-195 December 2004.
   
Publicatons, etc. before retirement in 1989
   
  255 research papers in English incl. Nature, etc and 156 review articles in English and Japanese, and Books,
       Brain Control of Blood Pressure, Elsevier (Amsterdam), 1989
     
Pharmacology of Major and Minor Tranquilizers, Asakura Publ Co. (Tokyo), 1971
   
  Presidents & organizers for annual scientific congresses and business symposia
       5th International Pharma Licensing Symposium (IPLS, attended by 340 firms ww)
       in Tokyo, 2001, (one week after September 11 2011, twin tower attacks, NY)
       2nd International Pharma Licensing Symposium (IPLS, attended by 255 firms ww) in
     Yokohama, 1998
 

     22nd Annual Psychoneuropharmacological Symposium, in Ooiso, 1988
     International Symposium on Blood Pressure and Brain, in Tokyo, 1987
     19th Annual Congress on Hypertension and SHR in Kamakura, 1985.